Advances in Small-Molecule Manufacturing
Webinar Date/Time: Fri, Feb 7, 2025 11:00 AM EST
Find out more about recent advances shaping small-molecule drug manufacturing, such as technological innovations and QbD principles that are enabling greater efficiency and improvements. Additionally, hear about potential emerging trends that may impact small-molecule manufacturing in the near future.
Register Free: https://www.pharmtech.com/pt_w/small-molecule-manufacturing
Event Overview:
In this exclusive Drug Digest video interview, Felicity Thomas, Associate Editorial Director, and Patrick Lavery, Editor, Pharmaceutical Technology Group, interview experts about advances in small-molecule manufacturing. During the discussion, various experts will detail recent advances that have enabled improvements in small-molecule manufacturing, such as technological innovations, quality-by-design principles, and complexity management. Additionally, sustainability initiatives and emerging trends will be touched upon.
Interviews featuring:
- Expert from Thermo Fisher Scientific
- A selection of speakers from CPHI interviews
Key Learning Objectives:
- Learning about recent advances shaping small-molecule drug manufacturing.
- Discovering technological innovations and QbD principles guiding more efficient small-molecule manufacturing.
- Highlighting emerging trends that will impact small-molecule manufacturing in the future.
Who Should Attend:
- Manufacturers
- Solid dosage drug manufacturers
- Quality personnel
- CDMOs
- Manufacturing operations personnel
- Engineers
Register Free: https://www.pharmtech.com/pt_w/small-molecule-manufacturing
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
